相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment
Nicoleta C. Olarescu et al.
NEUROENDOCRINOLOGY (2016)
Acromegaly and cancer: an old debate revisited
Cesar Luiz Boguszewski et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
Jakob Dal et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays
Philippe Chanson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes
Lesly A. Portocarrero-Ortiz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study
Emmanuelle Kuhn et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey
Christof Schoefl et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Treatment Outcome Results from the Bulgarian Acromegaly Database: Adjuvant Dopamine Agonist Therapy is Efficient in Less than One Fifth of Non-irradiated Patients
S. Vandeva et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2015)
Prospective Study of Surgical Treatment of Acromegaly: Effects on Ghrelin, Weight, Adiposity, and Markers of CV Risk
Carlos Reyes-Vidal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Successful Mortality Reduction and Control of Comorbidities in Patients With Acromegaly Followed at a Highly Specialized Multidisciplinary Clinic
Moises Mercado et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
EXPERT CONSENSUS DOCUMENT A consensus on the medical treatment of acromegaly
Andrea Giustina et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry
Roberto Salvatori et al.
PITUITARY (2014)
Emerging trends in the diagnosis and treatment of acromegaly in Canada
Sophie Vallette et al.
CLINICAL ENDOCRINOLOGY (2013)
Nationwide survey of acromegaly in South Korea
Obin Kwon et al.
CLINICAL ENDOCRINOLOGY (2013)
Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register
Christof Schoefl et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)
Gemma Sesmilo et al.
PITUITARY (2013)
A consensus on the diagnosis and treatment of acromegaly complications
S. Melmed et al.
PITUITARY (2013)
Predictors of morbidity and mortality in acromegaly: an Italian survey
M. Arosio et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Epidemiology, treatment trends and outcomes of acromegaly
Cecilia Mercieca et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
A. J. van der Lely et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
Ferdinand Roelfsema et al.
PITUITARY (2012)
Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays
David R. Clemmons
CLINICAL CHEMISTRY (2011)
The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly
C. N. Jayasena et al.
CLINICAL ENDOCRINOLOGY (2011)
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
Sandrine Fieffe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Acromegaly: presentation, morbidity and treatment outcomes at a single centre
P. Anagnostis et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Mortality in Patients with Pituitary Disease
Mark Sherlock et al.
ENDOCRINE REVIEWS (2010)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
Theodoros Rokkas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
AcroBel - the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects
Marie Bex et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Medical progress: Acromegaly
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Consensus statement: medical management of acromegaly
S Melmed et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
A nationwide survey of mortality in acromegaly
R Kauppinen-Mäkelin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Factors influencing mortality in acromegaly
IM Holdaway et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espahol de Acromegalia, REA)
A Mestrón et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Acromegaly consensus: The next steps
A Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Gender- and age-related differences in the endocrine parameters of acromegaly
A Colao et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2002)
Criteria for cure of acromegaly: A consensus statement
A Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
分享论文
